105 related articles for article (PubMed ID: 19273517)
1. Prominent celecoxib researcher admits fabricating data in 21 articles.
Lenzer J
BMJ; 2009 Mar; 338():b966. PubMed ID: 19273517
[No Abstract] [Full Text] [Related]
2. Antitumoral effect of celecoxib in hepatocellular carcinoma.
Malka D; Pacault V; De Baere T; Ducreux M; Boige V
J Clin Oncol; 2005 Jul; 23(21):4805-6. PubMed ID: 16034068
[No Abstract] [Full Text] [Related]
3. [Pre-clinical and clinical profiles of celecoxib, a new specific cyclooxygenase-2 inhibitor].
Kimoto A; Hanaoka A; Sasamata M; Miyata K
Nihon Yakurigaku Zasshi; 2008 Feb; 131(2):127-36. PubMed ID: 18277013
[No Abstract] [Full Text] [Related]
4. Selective cyclooxygenase-2 inhibition produces heterogeneous erythema response to ultraviolet irradiation.
Rodriguez-Burford C; Tu JH; Mercurio M; Carey D; Han R; Gordon G; Niwas S; Bell W; Elmets CA; Grizzle W; Pentland AP
J Invest Dermatol; 2005 Dec; 125(6):1317-20. PubMed ID: 16354205
[No Abstract] [Full Text] [Related]
5. New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).
Cotter J; Wooltorton E
CMAJ; 2005 May; 172(10):1299. PubMed ID: 15833921
[No Abstract] [Full Text] [Related]
6. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
Hawk E; Viner JL
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):185-7. PubMed ID: 17301246
[No Abstract] [Full Text] [Related]
7. Determine whether perioperative celecoxib administration would reduce opioid consumption and provide effective pain relief in patients undergoing arthroscopic knee surgery.
Ekman EF; Berger M; Bhadra P
Arthroscopy; 2006 Jul; 22(7):804. PubMed ID: 16843817
[No Abstract] [Full Text] [Related]
8. Celecoxib: new indication. Ankylosing spondylitis: no pain justifies the use of a cox-2 inhibitor. Patients still exposed to unjustified risks.
Prescrire Int; 2008 Jun; 17(95):106. PubMed ID: 18627117
[No Abstract] [Full Text] [Related]
9. Balancing the risks and benefits of celecoxib.
Caldwell B; Beasley R; Weatherall M; Metcalfe S
Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
[No Abstract] [Full Text] [Related]
10. PSA and clinical responses to celecoxib in a patient with prostate cancer and bone metastases.
Sonpavde G; Hayes TG
Mayo Clin Proc; 2005 Aug; 80(8):1100-1. PubMed ID: 16092593
[No Abstract] [Full Text] [Related]
11. Editorial comment on: celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma.
Brandau S
Eur Urol; 2008 Sep; 54(3):629-30. PubMed ID: 18222602
[No Abstract] [Full Text] [Related]
12. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
13. Preventing chronic pain after surgery: who, how, and when?
Eisenach JC
Reg Anesth Pain Med; 2006; 31(1):1-3. PubMed ID: 16418016
[No Abstract] [Full Text] [Related]
14. Celecoxib-induced deep-vein thrombosis.
Chan AL
Ann Pharmacother; 2005 Jun; 39(6):1138. PubMed ID: 15840730
[No Abstract] [Full Text] [Related]
15. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
Becker MR; Gaiser T
Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209
[No Abstract] [Full Text] [Related]
16. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
Backhus LM; Petasis NA; Uddin J; Schönthal AH; Bart RD; Lin Y; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1406-12. PubMed ID: 16256796
[TBL] [Abstract][Full Text] [Related]
17. The use of celecoxib for reduction of pain after subpectoral breast augmentation.
Parsa AA; Soon CW; Parsa FD
Aesthetic Plast Surg; 2005; 29(6):441-4; discussion 445. PubMed ID: 16328638
[TBL] [Abstract][Full Text] [Related]
18. The cyclooxygenase-2 inhibitor celecoxib and alveolar osteitis.
Al-Sukhun J; Penttilä H
J Ir Dent Assoc; 2011; 57(1):50-3. PubMed ID: 21413548
[TBL] [Abstract][Full Text] [Related]
19. Did targeted therapy fail cyclooxygenase too?
Csiki I; Johnson DH
J Clin Oncol; 2006 Oct; 24(30):4798-800. PubMed ID: 17050864
[No Abstract] [Full Text] [Related]
20. [Current post-marketing information. Effects and adverse effects of celecoxib].
Schmidt H; Geisslinger G
Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
